- Posts by Sheila A. WoolsonMember of the Firm
Attorney Sheila Woolson focuses her practice on complex litigation matters across a wide array of commercial and employment disputes.
Sheila draws on her training as a chemist and her experience in the pharmaceutical industry as ...
Our colleagues Anthony Argiropoulos and Sheila A. Woolson have a post on the Workforce Bulletin blog that will be of interest to our readers in the health care and life sciences industry: “Coronavirus Emergency Declarations Trigger Anti-Price Gouging Laws.”
Following is an excerpt:
The particulars of the laws vary with each state. Some states set a percentage above which the merchant cannot increase the price. Others simply state the price increase cannot be “unconscionable.” Some laws apply to any party in the distribution chain, whereas others make allowances for ...
Blog Editors
Recent Updates
- Importance of Negotiating Maintenance, Repair and Replacement Obligations in Health Care Leases
- Unpacking Averages: Assessing the Products Included in FDA's Voluntary Malfunction Summary Reporting Program
- Federal Update on Cannabis Scheduling: Are State Legalized Cannabis Dispensaries to Become Pharmacies?
- HHS Extends the Antidiscrimination Provisions of the Affordable Care Act to Patient Care Decision Support Tools, Including Algorithms
- It’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs) as Medical Devices Has Arrived